-
APGE Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Apogee Therapeutics (APGE)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 119.07 mm | 119.07 mm | 119.07 mm | 119.07 mm | 119.07 mm | 119.07 mm |
Cash burn (monthly) | 62.84 mm | 5.77 mm | 19.56 mm | 14.85 mm | (no burn) | 1.49 mm |
Cash used (since last report) | 291.39 mm | 26.74 mm | 90.71 mm | 68.84 mm | n/a | 6.91 mm |
Cash remaining | -172.32 mm | 92.34 mm | 28.36 mm | 50.24 mm | n/a | 112.16 mm |
Runway (months of cash) | -2.7 | 16.0 | 1.4 | 3.4 | n/a | 75.2 |
13F holders | Current |
---|---|
Total holders | 143 |
Opened positions | 27 |
Closed positions | 25 |
Increased positions | 48 |
Reduced positions | 46 |
13F shares | Current |
---|---|
Total value | 3.22 tn |
Total shares | 62.17 mm |
Total puts | 259.40 k |
Total calls | 44.90 k |
Total put/call ratio | 5.8 |
Largest owners | Shares | Value |
---|---|---|
VR Adviser | 8.49 mm | $498.90 bn |
FMR | 7.50 mm | $440.70 bn |
Wellington Management | 4.81 mm | $282.80 bn |
Venrock Healthcare Capital Partners III | 3.89 mm | $80.47 mm |
BlackRock | 2.98 mm | $174.81 bn |
RTW Investments | 2.71 mm | $159.31 bn |
Driehaus Capital Management | 2.53 mm | $148.82 bn |
Access Industries Management | 2.19 mm | $120.25 mm |
Vanguard | 2.13 mm | $124.94 bn |
Fairmount Funds Management | 2.05 mm | $120.34 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Feb 25 | Michael Thomas Henderson | Common Stock | Sell | Dispose S | No | Yes | 40.58 | 15,000 | 608.70 k | 1,302,987 |
5 Feb 25 | Carl Dambkowski | Common Stock | Sell | Dispose S | No | Yes | 40.69 | 3,520 | 143.23 k | 252,623 |
5 Feb 25 | Carl Dambkowski | Common Stock | Option exercise | Acquire M | No | No | 22.86 | 795 | 18.17 k | 256,143 |
5 Feb 25 | Carl Dambkowski | Stock Option Common Stock | Option exercise | Dispose M | No | No | 22.86 | 795 | 18.17 k | 171,375 |
31 Jan 25 | Michael Thomas Henderson | Common Stock | Option exercise | Acquire M | No | No | 22.86 | 8,500 | 194.31 k | 1,317,987 |
31 Jan 25 | Michael Thomas Henderson | Stock Option Common Stock | Option exercise | Dispose M | No | No | 22.86 | 8,500 | 194.31 k | 390,012 |
8 Jan 25 | Michael Thomas Henderson | Common Stock | Sell | Dispose S | No | Yes | 49.38 | 2,868 | 141.62 k | 1,309,487 |
8 Jan 25 | Michael Thomas Henderson | Common Stock | Sell | Dispose S | No | Yes | 48.72 | 12,132 | 591.07 k | 1,312,355 |
2 Jan 25 | Carl Dambkowski | Common Stock | Sell | Dispose S | No | Yes | 47.92 | 100 | 4.79 k | 255,348 |
2 Jan 25 | Carl Dambkowski | Common Stock | Sell | Dispose S | No | Yes | 47.21 | 2,486 | 117.36 k | 255,448 |